TTK HEALTHCARE LIMITED
TTKHLTCARE · Capital Goods · NSE
₹891
Current Market Price
Fair Value (DCF)
₹676
Discount to FV
-24.1%
Updated just now
YieldIQ Score
30/100
Piotroski F-Score
5/9
Economic Moat
None
Confidence
42%
ROE
7.7%
Debt/Equity
0.02
WACC
11.1%
Market Cap
₹1,259 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
10.9%
Return on capital employed
EV / EBITDA
30.3×
Enterprise multiple
Debt / EBITDA
1.1×
Leverage vs earnings
Interest Coverage
56.6×
EBIT covers interest
Current Ratio
5.23×
Short-term liquidity
Asset Turnover
0.67×
Revenue per ₹ of assets
Revenue CAGR (3Y)
6.0%
3-year revenue growth
Revenue CAGR (5Y)
6.1%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹891.05
Bear case
Margin of Safety -600.7%
Implied upside -85.7%
Base case
Margin of Safety -46.5%
Implied upside -31.7%
Bull case
Margin of Safety +7.6%
Implied upside +8.2%
Ratio Trends
TTKHLTCARE · last 6 annual periods
ROE
7.7%
ROCE
10.9%
Operating Margin
—
Debt / Equity
0.02×
PE
86.6×
EV / EBITDA
18.6×
Historical Financials
TTKHLTCARE · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹596 Cr | ₹720 Cr | ₹748 Cr | ₹801 Cr | ₹857 Cr | +9.5% |
| EBITDA | ₹41.3 Cr | ₹79.8 Cr | ₹99.1 Cr | ₹120 Cr | ₹94.3 Cr | +22.9% |
| EBIT | ₹28.1 Cr | ₹66.9 Cr | ₹86.9 Cr | — | — | +32.6% |
| PAT | ₹41.6 Cr | ₹640 Cr | ₹62.8 Cr | ₹81.7 Cr | ₹65.7 Cr | +12.1% |
| EPS (diluted) | ₹13.10 | ₹31.61 | ₹44.47 | — | — | +35.7% |
| CFO | ₹45.0 Cr | ₹-24.8 Cr | ₹-4.9 Cr | ₹-4.0 Cr | ₹-21.1 Cr | — |
| CapEx | ₹-5.5 Cr | ₹-11.7 Cr | ₹-10.4 Cr | ₹-12.8 Cr | ₹-5.8 Cr | — |
| FCF | ₹39.5 Cr | ₹-36.5 Cr | ₹-15.3 Cr | ₹-16.8 Cr | ₹-27.0 Cr | — |
| Total Assets | ₹559 Cr | ₹1170 Cr | ₹1206 Cr | ₹1281 Cr | ₹1329 Cr | +24.2% |
| Total Debt | ₹22.2 Cr | ₹27.3 Cr | ₹22.8 Cr | ₹24.2 Cr | ₹24.4 Cr | +2.4% |
| Shareholders' Equity | ₹330 Cr | ₹953 Cr | ₹1001 Cr | ₹1065 Cr | ₹1115 Cr | +35.6% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
TTKHLTCARE vs 4 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 NGLFINE NGLFINE | — | — | Pending | 14.6% | — |
SAIPARENT SAIPARENT | — | — | Pending | 15.9% | — |
SMSPHARMA SMSPHARMA | — | — | Pending | 10.8% | — |
SENORES SENORES | — | — | Pending | 7.2% | — |
Click a ticker to view its fair-value analysis.
Dividend History
10 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹46.00/sh
Last payout
2025-07-18
₹10.00
Peak payout
₹10.00
Trailing yield
1.12%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. TTK HEALTHCARE LIMITED (TTKHLTCARE.NS) trades at 891.05 vs a model fair value of 676.43, a gap of -24.1%. Piotroski F-score: 5/9. Moat la...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of TTKHLTCARE →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for TTKHLTCARE →
Compare
Head-to-head with peers
Compare TTKHLTCARE side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse TTKHLTCARENow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.